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Abstract
Background: Biomass combustion contributes to the production of ambient particulate matter (PM) in rural
environments as well as urban settings, but relatively little is known about the health effects of these emissions.
The aim of this study was therefore to characterize airway responses in humans exposed to wood smoke PM
under controlled conditions. Nineteen healthy volunteers were exposed to both wood smoke, at a particulate
matter (PM2.5) concentration of 224 ± 22 μg/m
3, and filtered air for three hours with intermittent exercise. The
wood smoke was generated employing an experimental set-up with an adjustable wood pellet boiler system
under incomplete combustion. Symptoms, lung function, and exhaled NO were measured over exposures, with
bronchoscopy performed 24 h post-exposure for characterisation of airway inflammatory and antioxidant responses
in airway lavages.
Results: Glutathione (GSH) concentrations were enhanced in bronchoalveolar lavage (BAL) after wood smoke
exposure vs. air (p = 0.025), together with an increase in upper airway symptoms. Neither lung function, exhaled
NO nor systemic nor airway inflammatory parameters in BAL and bronchial mucosal biopsies were significantly
affected.
Conclusions: Exposure of healthy subjects to wood smoke, derived from an experimental wood pellet boiler
operating under incomplete combustion conditions with PM emissions dominated by organic matter, caused an
increase in mucosal symptoms and GSH in the alveolar respiratory tract lining fluids but no acute airway
inflammatory responses. We contend that this response reflects a mobilisation of GSH to the air-lung interface,
consistent with a protective adaptation to the investigated wood smoke exposure.
Background
Within the European Community there is an increasing
commitment for replacing the present dependence on
fossil fuel energy sources with renewable CO2-neutral
alternatives. By 2020, the member states of the Eur-
opean Union are committed to a target of 20% of their
energy requirements from renewable sources, including
biomass. Although the scheme supports many types of
renewable heat, special concern has been expressed to
the urban air pollution health impact presently arising
from traditional wood log installations, and the potential
increase in new small and medium scale biomass
heating systems [1-4]. Combustion-derived particulate
matter (PM) air pollution has been widely considered to
be associated with adverse respiratory and cardiovascu-
lar health effects [3,4]. In many European countries,
residential biomass combustion contributes substantially
to the fine particulate emissions (PM2.5), which has also
been confirmed in other parts of the world including
the US where a range of 8-85% has been given [1,5-8].
T h ee m i s s i o n sa r em a i n l yd ue to the use of present old
and non-optimised, small biomass combustion systems.
The negative impact on health of biomass combustion
has been demonstrated by the higher occurrence of
respiratory symptoms and respiratory-related hospital
admissions, among populations living in areas with a
high wood smoke-derived contribution to ambient PM
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reproduction in any medium, provided the original work is properly cited.[3,9-14]. Asthmatic subjects have been shown to be
particularly sensitive to wood smoke [10,12,15].
To date, only a few experimental studies have investi-
gated the toxicity of wood smoke derived PM to compli-
ment the epidemiological observations. Cell culture
studies have shown that exposure to wood smoke parti-
cles results in the release of pro-inflammatory cytokines,
affects cell viability and induces oxidative stress and
DNA damage [3,16,17]. These findings are to some
extent similar to those reported after in vitro challenges
of airway cells to diesel exhaust-derived and other ambi-
ent air pollution particles [18-21]. Further, the first
human in vivo study examining the effects of wood
smoke has recently been reported [22-24]. The investi-
gators employed batch wise firing of log wood in a cast
iron stove with healthy subjects exposed to diluted
wood smoke at PM2.5 concentration of about 250 μg/m
3
for four hours. This was associated with minor increases
in amyloid A protein and altered coagulation factor
ratios in blood, increased exhaled nitric oxide and oxi-
dative stress reflected by increased malondialdehyde in
exhaled breath condensate [22-24].
Whilst these papers have relied on indirect measures
of airway inflammation and oxidative stress, the present
study was performed employing bronchoscopy based
lavage which may give a clearer picture of the responses
occurring at the air-lung interface following wood
smoke inhalation. The primary hypothesis was that
exposure to wood smoke would cause an inflammatory
response in human airways, triggered through the impo-
sition of oxidative stress, as has been demonstrated in
humans following diesel exhaust challenges [25-29].
Methods
Subjects
Nineteen healthy, non-smoking non-allergic volunteers
(10 males/9 females) with a mean age of 24 years (range
21-31 years) were recruited. All had negative skin prick
tests against a standard panel of aero-allergens and nor-
mal lung function. All subjects refrained from medica-
tion, including vitamin or antioxidant supplementation
for the duration of the study and were free from symp-
toms of airway infection for a six week period prior the
wood smoke and air exposures. The local ethics com-
mittee (Umeå University, Umeå, Sweden) approved the
study and all participants gave their informed written
consent. The study was conducted according to the
declaration of Helsinki.
Exposure
Subjects were exposed on two different occasions in a
randomised, double blinded fashion; once to filtered air
and once to diluted wood smoke-derived emissions in a
purpose-built exposure chamber (18 m
2,s u i t a b l ef o r
1-2 persons) at Umeå University, with an interval of at
least three weeks. Each exposure lasted for three hours,
during which the subjects alternated between 15-minute
intervals of exercise on a bicycle ergometer (minute ven-
tilation 20 L min
-1 m
-2 body surface) and rest. The fil-
tered air, with or without diluted biomass combustion
emissions was introduced through the ceiling by air dis-
tributors and were driven by a slight overpressure
through openings at floor level to an antechamber. The
residence time of the filtered air/wood smoke in the
exposure chamber was approximately 6 minutes.
Combustion system and exposure conditions
The biomass combustion emissions were generated
using a typical residential wood pellet burner (nominal
effect 15 kW) installed in a reference boiler. A moist
softwood pellet/sawdust fuel mixture from pine and
spruce (18% moisture) was burnt under adjusted com-
bustion conditions, i.e. low temperature (700-800°C) and
reduced air/fuel mixing, to simulate wood smoke emis-
sions from incomplete combustion. The combustion
conditions were monitored by measuring O2 and CO
concentrations in the flue gases, as well as the tempera-
ture in the combustion zone. The incomplete combus-
tion conditions resulted in flue gas (i.e. undiluted
emissions) with CO concentrations of 1000-5000 ppm
and O2 levels of 6-11%. A fraction of the emissions was
subsequently cooled and diluted using a three steps
dilution system to the desired PM concentration. Mea-
surements of gases and particles in the chamber were
performed in order to monitor and control the exposure
conditions. The flue gases were diluted 200-300 times
with an average air-exchanged rate of 10/h during the
exposures. The temperature in the chamber was main-
tained between 21-24°C with a relative humidity 20-50%.
The concentrations of CO and NOx (dominated by
NO) in the chamber were monitored continuously and
varied in the range of 5-15 ppm and 0.2-0.4 ppm,
respectively. The concentration of two volatile organic
compounds, i.e.1.3-butadiene and benzene, were deter-
mined during five exposures by SKC Ultra passive
(diffusive) samplers and gas chromatography analysis.
The concentrations of 1.3-butadiene and benzene were
11.0 ± 2.8 μg/m
3 and 81.8 ± 14.3 μg/m
3, respectively.
The fine particle mass concentration in the chamber
was monitored by a Tapered Element Oscillating
Microbalance (TEOM 1400) equipped with a PM2.5
pre-cyclone. The operation temperature of the TEOM
was set to 30°C, instead of the standard of 50°C, which
aimed at reducing potential evaporation of particulate
organic material from the filter. To avoid water con-
densation at this lower temperature, a Nafion dryer
(Perma Pure LLC) was used after the cyclone but
b e f o r et h eT E O M .T h ef i n eP Mi nt h ec h a m b e rv a r i e d
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3 during each exposure
with an average of the mean concentration from all
exposures of 224 ± 22 μg/m
3.
The particle mass size distribution in the chamber was
measured with a 13 stage low-pressure cascade impactor
in the range of 0.03-10 μm (aerodynamic diameter) dur-
ing two exposure occasions. The mass median diameter
(MMDa)o ft h ef i n eP Mw a s0 . 2 1 8μm and 0.228 μm
d u r i n gt h e s et w oo c c a s i o n s .T h ef i n ep a r t i c l en u m b e r
size distribution and concentration in the chamber was
measured during five exposure occasions by a scanning
mobility particle sizer (SMPS) system, in the range of
0.016 to 1.00 μm (equivalent mobility diameter). The
particle number concentration varied in the range of 5-
10 ×10
4 cm
-3 with a mean concentration of 6.7 ± 0.9 ×
10
4 cm
-3. The geometric mean diameter (GMDm)w a s
0.120 ± 0.018 μm (mean ± SD), with a geometric stan-
dard deviation (sg) of the size distribution of 1.81 ±
0.06. However, a log-normal mode fitting calculation
showed that the number size distribution comprised two
distinct modes (mode peak diameter at 0.100 and 0.190
μm, respectively) which show that the wood smoke
aerosol was an external mixture of two different particle
types. Corresponding measurements in the filtered air
used for the “clean air” exposures showed a particle
number concentration of 1-2 cm
-3.
The PM was characterized chemically regarding car-
bon fractionation in organic and elemental carbon (OC/
EC), major inorganic ions, trace elements and polycyclic
aromatic hydrocarbons (PAH).
The fraction of OC and EC of the PM in the chamber
was determined by thermal-optical carbon analysis
(Method NIOSH 5040) using quartz and teflon+quartz
filters in parallel according to standard procedures [30].
A relatively high OC/EC ratio was determined for the
present wood smoke PM. Major inorganic ions were
also analyzed by ion chromatography (IC) after ultraso-
nification of the Teflon filter samples collected by the
OC/EC measurements. The dominating ions were K
+,
SO4
2-,C O 3
2- and Cl
-,i . e .a l k a l is a l t sl i k eK 2SO4,K 2CO3
and KCl. The PM in the chamber was also sampled on
specific polycarbonate filters for analysis of trace ele-
ments (Z > 12) by Particle-Induced X-ray Emission
(PIXE) technique. Zn was the dominating trace element
followed by Mo, Rb and Pb. Thus, an overall estimated
chemical fractionation of the used diluted wood smoke
revealed that the PM consisted of 60% OC, 25% EC,
13% alkali salts and 2% trace elements.
Further, measurements of PAH in the chamber was
performed during three exposure occasions by sampling
with glass fibre filters for the particulate fraction fol-
l o w e db yap o l y u r e t h a n ef o a m( P U F )p l u gf o rt h es e m i -
volatile fraction. 45 specific PAH compounds were ana-
lyzed by gas chromatography-mass spectrometry (GC-
MS), according to procedures described previously [31].
The total PAH (particulate and semi-volatile) concentra-
tion was 757 ± 167 ng/m
3 where 74-88% was semi-vola-
tile. Dominating PAH’s in the semi-volatile fractions
were Phenanthrene and Fluorene followed by Anthra-
cene, Fluoranthene, Pyrene and Methylphenanthrenes.
In the particulate fraction Benzo(b)fluoranthene totally
dominated, followed by e.g. Fluoranthene, Benzo(e)pyr-
ene, Pyrene, Cyclopenta(cd)pyrene, Benzo(c)phenan-
threne, Phenanthrene and Benzo(a)pyrene.
Assessment of lung function and symptom perception
Lung function tests including vital capacity (VC), forced
vital capacity (FVC) and forced expiratory capacity in
one second (FEV1), were performed pre-exposure as
well as immediately after, 4 and 24 hours post-exposure
using a Vitalograph® spirometer (Buckingham, UK). The
perceived intensity of a range of symptoms was recorded
by the subjects at seven different time points; before,
every 30 minutes during the exposure and immediately
after each exposure. The symptoms were scored with a
ranking from 0 (no symptoms) to a maximum of 11,
according to a modified Borg scale [32], as previously
reported [33]. The protocol included questions of
unpleasant smell or taste, eye, nasal or throat irritation,
cough, nausea, headache, difficulty in breathing, tired-
ness and chest tightness.
The fraction of exhaled nitric oxide
FENO concentrations were evaluated pre exposure,
immediately after, 4 and 24 hours post-exposure, using
a nitric oxide analyzer (NIOX®, Aerocrine AB, Stock-
holm, Sweden). Four different exhalation flow rates; 10,
50, 100 and 270 mL×s
-1 (± 10%), during a slow exhala-
tion against an oral pressure of 2 cm H2O for 25, 10, 8
and 6 seconds respectively were examined. The mea-
surements were conducted in triplicate at each flow rate
and the mean concentration of exhaled NO (ppb) was
registered according to ERS/ATS guidelines [34].
Airway lavage based analyses
Bronchoscopy was performed 24 hours post-exposure
using a flexible video bronchoscope (Olympus BF IT160;
Olympus, Tokyo, Japan), as previously described [26,29].
Bronchial wash (BW) with 2 × 20 ml and bronchoalveolar
lavage (BAL) with 3 × 60 ml sterile phosphate-buffered
saline (PBS) (pH 7.3, 37°C) was performed. The BW and
BAL samples were collected into separate siliconised
containers and immediately placed on ice. They were
then filtered through a nylon filter (pore diameter 100
μm; Syntab AB, Malmö, Sweden) and centrifuged at 400 g
for 15 minutes. Cell pellets derived from the first bron-
chial (BWI) and the pooled BAL aspirates were resus-
pended in PBS at a cell concentration of 10
6 cells/ml
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fuge slides stained with May-Grünwald Giemsa, counting
400 cells per slide [26,29]. The phagoctyic activation/
degranulation markers myeloperoxidase (MPO) (Bio-
Check, Inc., CA, USA) and matrixmetalloproteinase 9
( M M P - 9 )( R & DS y s t e m s ,I n c . ,M N ,U S A )w e r ea n a l y s e d
in the cell free lavage supernatants derived from the first
BW fraction and BAL, using commercially available
enzyme linked immunosorbent assay kits.
Antioxidant analysis
Cell-free BW (second fraction) and BAL supernatants
were analysed for total protein, glutathione (GSH and
glutathione disulphide (GSSG)), vitamin C (ascorbate
and dehydroascorbate), and urate concentration. Total
protein was measured by reaction with bicinchoninic
acid and 4% copper (II) sulphate, following the method
of Smith et al. [35]. Total glutathione concentrations
were measured using the GSSG-reductase-DTNB recy-
cling method [36,37]. Ascorbate and urate were mea-
sured simultaneously by reverse phase HPLC with
electrochemical detection, as previously described [38].
Total vitamin C (dehydroascorbate + ascorbate) was
measured by pre-treating samples with 50 mM Tris(2-
carboxylethyl) phosphine for 15 minutes to reduce oxi-
dised ascorbate and then performing the lipid extraction
and HPLC analysis as described above. The dehydroas-
corbate concentration was then calculated by subtract-
ing the ascorbate concentration from the total vitamin
C concentration.
Endobronchial biopsies were also taken during
bronchoscopy and snap-frozen before storage at -80°C.
Biopsies were then homogenised and analysed for their
total protein, glutathione, ascorbate and urate concen-
trations, as described previously, as well as their heme
oxygenase 1 (HO-1) protein concentration and glu-
tathione S-transferase (GST) activity. Biopsies were
thawed on ice prior to homogenisation and placed in
100 mM sodium phosphate extraction buffer (pH 7.5).
Zirconium beads were added and vortexed for 5 minutes
to disrupt the cells and the resulting homogenate used
for analysis. HO-1 protein concentration was measured
by an ELISA from Stressgen Reagents (Ann Arbor, MI,
USA), and the glutathione S-transferase activity mea-
sured using an assay kit from Sigma Aldrich (Poole, UK,
catalogue number CS0410) and employed 1-Chloro-2,4-
dinitrobenzene (CDNB) as a substrate as it is suitable
for the broadest range of GST isozymes.
Statistical analysis
All biomedical analyses were carried out in pairs with
the subject acting as his/her own control; comparing air
exposure data to the corresponding time-point data col-
lected following wood smoke exposure. The symptom
data were analysed using the non-parametric Kruskal-
Wallis test. Lung function, FENO and peripheral blood
cell counts were analysed using a repeated measures
ANOVA, with data presented as mean +/- standard
error of mean (SEM). The comparison of airway inflam-
matory and antioxidant markers between the two expo-
sures were calculated using the non-parametric
Wilcoxon’s Signed Rank test, with data presented as
median and IQR (inter quartile range). The correlation
analyses were carried out using the Spearman-Rank test.
In all cases, a significant difference was assumed at the
5% level. All statistical analyses were performed using
SPSS® version 17.0 (SPSS inc., Chicago, IL, USA).
Results
All subjects tolerated the exposures and bronchoscopy
procedures well, with equivalent bronchial and bronch-
oalveolar lavage recoveries from all 19 subjects post air
and wood smoke exposure.
No significant changes were observed in lung function,
i.e. vital capacity (VC), forced vital capacity (FVC) and
forced expiratory capacity in one second (FEV1)o r
exhaled NO (FENO) at any of the time points examined
after the wood smoke challenge (data not shown).
Despite this, subjects reported mild but progressive irri-
tation in the nose and throat during the wood smoke
exposures (p < 0.001), peaking between 1.5 and 2.5
hours into the exposure, figure 1. Subjects also reported
an awareness of an unpleasant smell during the wood
smoke exposures (p < 0.001), figure 1. It was notable
that a subset of the subjects (7-10 of the 19) exposed to
wood smoke reported no symptoms.
There were also no significant changes determined in
the differential cell counts in bronchial wash (BW) and
bronchoalveolar lavage (BAL) fluid samples obtained
24 hours post air and wood smoke exposures, table 1.
The concentration of MPO and MMP-9 were also unal-
t e r e di nB A La n dB Wf o l l o w i n gt h ew o o ds m o k ec h a l -
lenge, table 1.
Of the low molecular weight antioxidants examined in
BW and BAL (ascorbate, urate and glutathione) only
BAL GSH was found to be significantly increased fol-
lowing wood smoke exposure (p = 0.025), table 2,
though a considerable inter-individual variation in
response was observed, figure 2. The wood smoke
induced increase in lower airway respiratory tract fluid
GSH occurred in the absence of increased GSSG con-
centrations suggesting the absence of oxidative stress at
this late time point post-exposure. No wood smoke-
induced alteration in low molecular weight antioxidant
concentrations was observed in the endobronchial
mucosal biopsies, table 3. Neither was there any evi-
dence of an induction of HO-1 protein or increased
GST activity post wood smoke, table 3.
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Page 4 of 11Figure 1 Intensity of recorded symptoms. The intensity of the prominent symptoms (unpleasant smell, throat and nasal irritation) observed in
subjects exposed to wood smoke (gray box plots) and filtered air. Intensity scores are presented as median values (central line) with the inter-
quartile range (box) and 95
th percentiles (whiskers). The number of subject exhibiting symptoms is recorded for each of the symptoms, together
with the level of significance determined using the Kruskal-Wallis test.
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GSH concentrations and wood smoke-induced GSH
responses.
A significant negative correlation was observed
between the baseline GSH concentration and the GSH
response to wood smoke, which was stronger in the
bronchial wash (r = -0.839, p < 0.001) than in the BAL
samples (r = -0.601, p = 0.011). A similar pattern was
observed in biopsy tissues, despite the absence of a sig-
nificant GSH tissue response: r = −0.797, p < 0.001.
These data suggest that the greatest induction and
mobilisation of GSH to the air-lung interface occurred
in those subjects with low baseline GSH concentrations.
Discussion
The present study investigated the impact of a relatively
high dose of wood smoke-derived particulate matter
(224 μg/m
3 PM2.5 for 3 hours) on airway function,
inflammation and the endogenous antioxidant defences
at the air-lung interface. Exposure to wood smoke
resulted in significantly increased levels of reduced glu-
tathione in bronchoalveolar lavage fluid from healthy
subjects sampled 24 hours after exposures, together with
increase in mucosal symptoms. There were no changes
in BAL cell numbers, mediator concentrations, lung
function or exhaled NO.
The current findings contrast markedly with the pat-
tern of response observed in subjects exposed to diesel
exhaust PM, at a lower total dose (PM10 300 μg/m
3 for
1h o u ro r1 0 0μg/m
3 for 2 hours). Proximal airway neu-
trophilia, lymphocytosis and mastocytosis was clearly
present 6-18 hour post exposure, associated with an up-
regulation of redox sensitive signalling and EGFR path-
ways in the bronchial mucosa together with increased
GSH concentrations in BAL fluid [25-29,39-41]. The
series of diesel exhaust studies in healthy subjects, and
individuals with respiratory and cardiovascular disease,
clearly support the notion of diesel exhaust to cause
wide spread inflammatory events and adverse cardiovas-
cular consequences [42-44].
The results of this study indicate that wood smoke, at
least from the presently investigated exposure situation,
is relatively non-toxic, as no significant inflammatory
responses or consumption of antioxidants at the airway
surface were demonstrated.
Table 1 Cell counts and inflammatory marker
concentrations in BW and BAL fluids
Bronchial Wash Bonchoalveolar Lavage
Post-Air Post-WS Post-Air Post-WS
Total cells 7.8 (6.3-11.5) 7.6 (5.7-10.2) 13.3 (8.3-
13.7)
11.2 (8.5-
14.3)
Macrophages 5.65 (3.73-
8.53)
5.43 (3.55-
7.66)
9.86 (7.28-
11.84)
9.07 (6.66-
12.87)
Neutrophils 1.73 (0.93-
3.09)
1.71 (0.97-
2.30)
0.25 (0.11-
0.54)
0.22 (0.09-
0.41)
Lymphocytes 0.40 (0.21-
0.68)
0.57 (0.21-
0.73)
1.29 (0.83-
2.08)
1.19 (0.76-
1.52)
Eosinophils 0.00 (0.00-
0.03)
0.01 (0.00-
0.03)
0.01 (0.00-
0.06)
0.01 (0.00-
0.04)
Mast cells 1.00 (0.00-
6.50)
2.00 (0.00-
7.00)
2.00 (0.00-
4.00)
2.00 (0.00-
5.00)
MPO ng/ml 8.62 (5.41-
18.00)
6.12 (4.31-
10.34)
0.59 (0.32-
1.39)
0.53 (0.40-
0.92)
MMP9 ng/ml 5.99 (3.33-
16.11)
4.41 (3.10-
6.77)
0.30 (0.24-
0.91)
0.27 (0.18-
0.48)
Cell counts and inflammatory marker concentrations in BW and BAL fluids
obtained from subjects exposed to wood smoke (mean 224 μg/m
3 PM2.5 for
3 hours) or filtered air with no significant difference in the responses
detected. Cell counts are given as cells × 10
4/ml. All data is expressed as
medians with interquartile ranges.
Table 2 Antioxidant and protein measurements in BW and BAL
Bronchial Wash Bronchoalveolar Lavage
Post-Air Post-WS Post-Air Post-WS
Total glutathione (μM) 0.76 (0.35-1.00) 0.94 (0.94-1.14) 0.73 (0.38-0.99) 0.87 * (0.64-1.45)
Glutathione (μM) 0.36 (0.25-0.75) 0.48 (0.31-0.91) 0.54 (0.32-0.74) 0.72 * (0.46-1.19)
Glutathione disulphide (μM) 0.11 (0.05-0.30) 0.20 (0.11-0.26) 0.07 (0.00-0.14) 0.04 (0.00-0.13)
% GSSG 23.0 (8.8-33.3) 16.9 (9.6-29.9) 7.78 (0.17-22.6) 3.58 (0.00-18.6)
Total vitamin C (μM) 0.36 (0.32-0.45) 0.42 (0.32-0.45) 0.50 (0.42-0.56) 0.53 (0.41-0.63)
Ascorbic acid (μM) 0.23 (0.21-0.31) 0.24 (0.21-0.32) 0.28 (0.24-0.39) 0.33 (0.13-0.45)
Dehydroascorbate (μM) 0.09 (0.05-0.13) 0.12 (0.08-0.15) 0.23 (0.15-0.30) 0.18 (0.15-0.31)
% oxidised vitamin C 29.9 (26.6-31.9) 29.2 (24.7-36.7) 33.1 (25.8-46.8) 30.3 (22.3-38.5)
Urate (μM) 0.90 (0.80-1.10) 0.86 (0.81-1.01) 0.79 (0.75-1.06) 0.80 (0.73-0.99)
Total protein (mg/ml) 0.17 (0.13-0.19) 0.14 (0.13-0.18) 0.14 (0.11-0.16) 0.14 (0.11-0.15)
Albumin (μg/ml) 17.0 (14.0-26.0) 18.0 (9.80-35.0) 30.0 (25.0-46.0) 33.0 (24.0-45.0)
Antioxidant and protein measurements in BW and BAL obtained from subjects exposed to wood smoke (mean 224 μg/m
3 PM2.5 for 3 hours) and filtered air. Data
are given as medians with inter-quartile range.
* Significant difference between exposures, p < 0.05
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samples can have some general compositional similari-
ties with diesel exhaust-derived particulates, but in sev-
eral aspects the physico-chemical properties differ.
Diesel exhaust particles mainly consist of two particle
types: soot agglomerates coated with condensed matter
(e.g. hydrocarbons and metallic ash) and volatile nuclei
mode particles with a high fraction of organics [45]. The
knowledge of the properties of wood smoke particles is
less advanced but the particles appear more hetero-
geneous, as highlighted when comparing different com-
bustion systems and combustion phases [3]. Wood
smoke typically contains a substantially higher fraction
of water soluble alkali salts and the organic fraction is
markedly different, containing higher oxygen content (e.
g. monosacharides and methoxyphenols). The trace ele-
ment composition is also different with wood smoke
typically being enriched in Zn. Finally, the properties of
the soot core (e.g. primary particle diameter, number of
primary particles and soot structure) may also be differ-
ent. Therefore, it can be expected that magnitude and
perhaps also the mechanisms of particle induced toxicity
may be markedly different for wood smoke compared to
diesel exhaust. Based on the presently investigated bio-
mass and combustion characteristics, wood smoke
appears to be less toxic to the airway than diesel exhaust
challenge, as reflected by a series of preceding investiga-
tions. This conclusion should however be tempered by
the knowledge that the organic and elemental composi-
tion of PM from biomass combustion varies significantly
depending on combustion conditions and fuel type [1,3].
We therefore acknowledge the possibility that other
combustion situations potentially could yield particles
with higher toxicity.
The only previous wood smoke exposures in healthy
subjects employed a batch fired wood log stove at a
broadly equivalent dose to the present study [22,23]. In
many aspects the conditions employed in the two stu-
dies were similar (summarised in table 4) though the
Figure 2 BAL and BW concentrations of glutathione (GSH). Glutathione (GSH) concentrations in BW and BAL fluid samples obtained from
subjects 24 hours after exposure to wood smoke (mean 224 μg/m
3 PM2.5) or filtered air for 3 hours. Individual responses, as well as group
medians, with inter-quartile ranges and 95-percentage confidence intervals are illustrated. Comparisons of the concentrations after air versus after
wood smoke were performed using the Wilcoxon’s Signed Rank test. P values are illustrated where these were significant. Non-significant
responses (NS) are also shown.
Table 3 Endobronchial biopsy concentrations of
antioxidants, antioxidant enzyme and protein
Air Wood smoke
Reduced GSH (μM/mg protein) 25.9 (19.3 -
29.3)
22.8 (20.2 -
27.5)
% GSSG 7.4 (4.5-9.9) 9.0 (6.6-15.8)
Ascorbate (μM/mg protein) 8.07 (6.35 -
10.1)
8.02 (6.67 -
10.2)
% DHA 23.1 (17.5-32.9) 23.0 (15.4-33.0)
Urate (μM/mg protein) 1.59 (1.09 -
2.24)
1.80 (0.11 -
2.85)
HO-1 (ng/mg protein) 7.32 (4.48 -
9.95)
7.52 (5.34 -
9.89)
Total Protein (mg/ml) 0.12 (0.09 -
0.16)
0.12 (0.10 -
0.14)
Glutathione S-transferase (U/mg
protein)
0.55 (0.39 -
0.82)
0.59 (0.37 -
0.84)
Antioxidant and protein concentrations as well as glutathione S-transferase
activity in endobronchial biopsies obtained from subjects exposed to wood
smoke (mean 224 μg/m
3 PM2.5 for 3 hours) and filtered air. No significant
differences between air and wood smoke were detected. Data are given as
medians with inter-quartile ranges.
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Page 7 of 11earlier exposure campaign reported considerably higher
number concentration of ultra fine particles which may
have played a role for partly differing outcomes between
the studies.
In contrast to previous animal and cell culture studies
employing wood smoke exposures in which oxidative
stress has observed [16,46,47], the present study failed
to demonstrate any evidence of decreased antioxidant
concentrations in the respiratory tract lining fluid or
increased concentrations of GSSG. In addition we
observed no evidence of an up-regulation of HO-1 or
GST in the bronchial tissues of subjects post wood
smoke, which has previously been observed in cell mod-
els challenged with PM reflecting protective adaptation
to the induction of oxidative stress [48]. The only wood
smoke-induced response observed was an increase in
BAL GSH, and we acknowledge the possibility of a
chance finding due to multiple analyses. We do, how-
ever, interpret this as a mobilisation of this antioxidant
to the distal lung respiratory tract lining fluids. Increases
in BAL GSH have been observed in response to other
oxidative challenges [49-51], however the source
of the additional GSH has never been identified.
Transcriptional regulation of the rate-limiting enzymes
involved in GSH synthesis are known to be redox-sensi-
tive [52,53]. Therefore, this response may reflect a pro-
tective increase in de novo GSH synthesis and regulated
transport out of the cell. However, GSH efflux from
cells has also been demonstrated to occur in apoptotic
cells before any plasma membrane leakage begins [54].
It is therefore possible, that the observed GSH increase
may be an early marker of apoptosis, although this
remains to be confirmed.
An additional aspect to consider is our recent findings
of differences in deposition in the respiratory tract of
wood smoke and motor engine particles in traffic
[55,56]. Deposition in the respiratory tract is primarily
dependent upon particle size, composition, hygroscopic
properties and individual parameters such as breathing
pattern and airway geometry. Wood smoke particles
generated under the same conditions as in this study
had, because of their size distribution and hygroscopi-
city, a low probability of depositing in the respiratory
tract. At similar inhaled mass concentration the deposi-
tion of motor exhaust particles in a traffic environment
was shown to be 16 times higher by particle number
Table 4 Comparison of the exposure conditions between the present study and previous studies by Barregård and
Sällsten
Parameter Unit Present study Preceding wood smoke exposures [22-24]
Temperature in chamber °C 21-24 23
Relative humidity in chamber % 20-50 35
Exchange rate of air in chamber times/hour ~10 ~2
NOx (approximately 90% as NO) ppm 0.2-0.4 0.6 and 0.7
CO ppm 5-15 13 and 9.1
1.3-Butadiene μg/m
3 11.0 ± 2.8 ~6 and ~4
Benzene μg/m
3 81.8 ± 14.3 ~30 and ~20
PM2.5 mass concentration (filter) μg/m
3 242 ± 8.2 and 272 ± 2
PM2.5 mass concentration (TEOM) μg/m
3 224 ± 22 ~130-230
Mass median diameter (MMDa) μm 0.218 and 228*
Particle number concentrations #/cm
3 6.7 ± 0.9×10
4 18.0×10
4 and 9.5×10
4
Geometric mean diameter (GMD) μm 0.120 ± 0.018** 0.042 and 0.112***
Geometric standard deviation (sg) 1.81 ± 0.06 1.7 and 1.4
Organic carbon (OC × 1.4) fraction % (of PMtot) ~60
Elemental carbon (EC) fraction % (of PMtot) ~25
Black smoke (BS) fraction % (of PMtot) ~30 and ~40
Total PAH concentration μg/m
3 0.76 ± 0.17****
0.68 ± 0.15***** 0.44 and 0.47*****
Semi-volatile PAH fraction % 74-88
PM-associated PAH fraction % 12-26
Inorganic major ions (alkali salts) % (of PMtot) ~13 ~4-5
Trace metals % (of PMtot)~ 2 ~ 2
* 2 of 13 exposure occasions
** measured with SMPS (i.e. given as equivalent mobility diameter)
*** measured with ELPI (i.e. given as aerodynamic particle diameter)
**** includes 45 specific PAH compounds (≥ 3 aromatic rings)
***** includes 13 specific (same) PAH compounds (≥ 3 aromatic rings)
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Page 8 of 11and 3 times higher by surface area. It has been demon-
strated that there is a correlation between the toxicity of
insoluble submicrometer particles and their total depos-
ited surface area [57]. Thus, it is probable that some of
the differences in health response may be explained by
variations in respiratory tract deposition.
Taken together, the present findings indicate a poten-
tial mobilisation of glutathione to the air-lung interface
in the absence of inflammatory cell recruitment into the
airways, oxidative stress or induction of mucosal xeno-
biotic enzymes (HO-1 and GST). This is interpreted as
an early response to PM, inferring a refinement to the
hierarchical response model which has been employed
to characterise the responses of cells to PM challenge
and oxidative stress [48,58]. We propose an initial air-
way tolerance/protection against oxidative stress related
to endogenous antioxidant defences in the RTLFs, and
speculate on an early antioxidant mobilisation to the air
way surface to prevent damage to the underlying epithe-
lium. The response observed in the present study may
therefore be considered as adaptive occurring before the
triggering of protective antioxidant/xenobiotic enzyme
expression under the regulation of Nrf2 [47,57]. It is
possible that other wood combustion situations that
generate different emission characteristics would yield
more pronounced effects, consistent with the responses
observed in in-vitro models [3], but this remains to be
tested under human challenge conditions.
Conclusions
The current study demonstrated that the healthy airway
is able to tolerate a relative l yh i g hd o s ee x p o s u r et o
wood smoke PM derived from the investigated combus-
tion situation. The only significant biological response
observed was an increase in GSH in the respiratory tract
lining fluids of the distal lung. As this was observed, in
the absence of inflammation or the induction of xeno-
biotic or antioxidant enzymes, we suggest that this
represents an early adaptive response, mobilising GSH
to the air lung interface. The impact of other wood
smoke and biomass combustion situations as well as
responses in individuals with pre-existing respiratory
and cardiovascular conditions remain to be determined
in order to widen the perspectives of biomass combus-
tion and health.
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